Search for: "N. LILLY"
Results 121 - 140
of 267
Sorted by Relevance
|
Sort by Date
7 Jul 2010, 5:14 am
(Patent Docs) (Holman's Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
28 Mar 2008, 7:42 am
Moving back in time, last week Paul N. [read post]
20 Mar 2012, 8:40 am
Eli Lilly & Co. [read post]
13 Jan 2010, 3:00 am
Actavis Elizabeth LLC (Docket Report) US: Inclusion of Pay-for-Delay ban in Health Care Bill urged; FTC to hold press conference announcing pay-for-delay analysis (FDA Law Blog) US: Drug molecules going off patent in 2010 (Patentcircle) Products Cipramil (Citalopram) - EU: Commission opens antitrust investigation into pharmaceutical company Lundbeck (EPLAW) (Managing IP) (GenericsWeb) Hectorol (Doxercalciferol) - US: Genzyme files patent infringement complaint against Cobrek in N D… [read post]
16 Mar 2010, 7:50 am
Sponsored by the Kansas Bar Ass'n. 110 Year Patent: Last week's Amazon 1-Click post included a typo suggesting that the patent would expire in the year 2107 (instead of 2017). [read post]
18 Sep 2007, 5:29 am
Eli Lilly and Co. , 488 F.3d 1026 (D.C.Cir. [read post]
6 Jul 2010, 6:03 pm
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
14 Sep 2011, 8:21 am
Hedgepath, 607 A.2d 1238, 1247 & n.8 (D.C. 1992); Miller v. [read post]
27 Jan 2024, 9:13 am
Ass’n, 211 So. 3d 1009 (Fla. 2016). [read post]
25 Oct 2008, 12:15 pm
Gaines 109,567 20,317 0 20,209 150,093 Karen N. [read post]
17 Jun 2008, 11:34 pm
Eli Lilly and Company, 65 NY2d 449, 492 NYS2d 584 (1985), "If the issue has not been litigated, there is no identity of issues between the present action and the prior determination. [read post]
7 Dec 2014, 3:29 pm
’, Eleonora asks Katfriend Jan Rosén (Stockholm University). [read post]
14 Oct 2022, 6:00 am
Dorilyn Morales Colón, BBA, MIS , Puerto Rico. [read post]
7 Jan 2014, 7:46 am
Supp. 2d 951, 957 n.3 (D. [read post]
15 Jun 2012, 10:38 am
”) (quoting Forum Corp. of N. [read post]
30 Apr 2024, 10:28 am
Egilman’s selective leaking of Eli Lilly documents was also a sore point. [read post]
25 Jun 2009, 4:29 am
Eli Lilly & Co., 536 F.Supp.2d 767, 781 (S.D. [read post]
10 Mar 2014, 11:31 am
Eli Lilly & Co., 504 F. [read post]
3 Mar 2016, 5:19 am
Last week’s “breaking news” post on West Virginia’s statutory restoration of the learned intermediary rule started us thinking about how every state now has pro-learned intermediary precedent. [read post]
24 Feb 2011, 1:49 pm
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 n.2 (S.D. [read post]
